HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Heart Journal 1995;74:261-267; doi:10.1136/hrt.74.3.261
Copyright © 1995 BMJ Publishing Group Ltd & British Cardiovascular Society

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edner, M.
Right arrow Articles by Rosenqvist, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edner, M.
Right arrow Articles by Rosenqvist, M.

Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation.

M. Edner, K. Caidahl, L. Bergfeldt, B. Darpö, N. Edvardsson, M. Rosenqvist

Department of Cardiology, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden.

BACKGROUND--In patients with drug resistant incessant supraventricular tachycardia, radiofrequency induced ablation of the atrioventricular junction and pacemaker implantation have hitherto been considered a treatment of last resort. OBJECTIVE--To assess the short and long term effects of ablation of the atrioventricular junction on systolic and diastolic left ventricular function in patients with atrial fibrillation with and without impaired left ventricular function. PATIENTS--29 patients (19 men; mean age 65 (SD 7) years (range 50-76)) undergoing ablation of the atrioventricular junction for drug refractory atrial fibrillation were examined a mean of 2, 65, and 216 days after ablation of the bundle of His. MAIN OUTCOME MEASURES--Left ventricular ejection fraction and early filling deceleration times (Edec) were assessed by Doppler echocardiography after 1 to 2 hours of ventricular pacing at a rate of 80 beats/minute. RESULTS--In 14 patients with a left ventricular ejection fraction < 50% left ventricular ejection fraction increased significantly from 32% (11%) to 39% (11%) (65 days) and 45% (11%) (216 days) (P < 0.001); Edec increased from 142 (46) ms to 169 (57) ms (65 days) and 167 (56) ms (216 days) (P < 0.05). In 15 patients with an ejection fraction > or = 50% at the initial examination no significant change in systolic function was observed. CONCLUSIONS--In patients with left ventricular dysfunction long term improvement of systolic and diastolic left ventricular function was seen after ablation of the atrioventricular junction for rate control of atrial fibrillation. This procedure had no adverse effects on normal left ventricular function.





This article has been cited by other articles:


Home page
EuropaceHome page
E. S. Tan, M. Rienstra, A. C.P. Wiesfeld, B. A. Schoonderwoerd, H. H.F. Hobbel, and I. C. Van Gelder
Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation
Europace, April 1, 2008; 10(4): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K.-T. Lim, M. J.E. Davis, A. Powell, L. Arnolda, K. Moulden, M. Bulsara, and R. Weerasooriya
Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial
Europace, July 1, 2007; 9(7): 498 - 505.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Stulak, J. A. Dearani, R. C. Daly, K. J. Zehr, T. M. Sundt III, and H. V. Schaff
Left Ventricular Dysfunction in Atrial Fibrillation: Restoration of Sinus Rhythm by the Cox-Maze Procedure Significantly Improves Systolic Function and Functional Status
Ann. Thorac. Surg., August 1, 2006; 82(2): 494 - 501.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
T. Szili-Torok, M. Bountioukos, A. J.Q.M. Muskens, D. A.M.J. Theuns, D. Poldermans, J. R.T.C. Roelandt, and L. J. Jordaens
The presence of contractile reserve has no predictive value for the evolution of left ventricular function following atrio-ventricular node ablation in patients with permanent atrial fibrillation
Eur J Echocardiogr, October 1, 2005; 6(5): 344 - 350.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Albage, G. Kenneback, J. van der Linden, and H. Berglund
Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure
Ann. Thorac. Surg., March 1, 2003; 75(3): 790 - 795.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Leclercq, S. Walker, C. Linde, J. Clementy, A.J. Marshall, P. Ritter, P. Djiane, P. Mabo, T. Levy, F. Gadler, et al.
Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation
Eur. Heart J., November 2, 2002; 23(22): 1780 - 1787.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Garrigue, P Bordachar, S Reuter, P Jais, A Kobeissi, G Gaggini, M Haissaguerre, and J Clementy
Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study
Heart, June 1, 2002; 87(6): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. R. Leon, J. M. Greenberg, N. Kanuru, C. M. Baker, F. V. Mera, A. L. Smith, J. J. Langberg, and D. B. DeLurgio
Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing
J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1258 - 1263.
[Full Text] [PDF]


Home page
EuropaceHome page
T. Szili-Torok, G. P. Kimman, D. Theuns, D. Poldermans, J. R. T. C. Roelandt, and L. J. Jordaens
Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation
Europace, January 1, 2002; 4(1): 61 - 65.
[Full Text] [PDF]


Home page
EuropaceHome page
J. C. Daubert and P. Mabo
Implantable devices to treat atrial fibrillation: real prospects or just new gimmicks?
Europace, January 1, 2002; 4(2): 161 - 164.
[PDF]


Home page
Eur Heart J SupplHome page
A. Capucci, G.Q. Villani, N. Marrazzo, and M. Piepoli
The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation
Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P47 - P52.
[Abstract] [PDF]


Home page
HeartHome page
T Levy, S Walker, M Mason, P Spurrell, S Rex, S Brant, and V Paul
Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study
Heart, February 1, 2001; 85(2): 171 - 178.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland
Systematic review of the management of atrial fibrillation in patients with heart failure
Eur. Heart J., April 2, 2000; 21(8): 614 - 632.
[Abstract] [PDF]


Home page
CirculationHome page
M. A. Wood, C. Brown-Mahoney, G. N. Kay, and K. A. Ellenbogen
Clinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation : A Meta-Analysis
Circulation, March 14, 2000; 101(10): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Deshmukh, D. A. Casavant, M. Romanyshyn, and K. Anderson
Permanent, Direct His-Bundle Pacing : A Novel Approach to Cardiac Pacing in Patients With Normal His-Purkinje Activation
Circulation, February 29, 2000; 101(8): 869 - 877.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Melo, P. Adragao, J. Neves, M. M. Ferreira, M. M. Pinto, M. J. Rebocho, L. Parreira, and T. Ramos
Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year
Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 851 - 855.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T LEVY, S WALKER, and V PAUL
AV node ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory PAF
Heart, April 1, 1999; 81(4): 450a - 451.
[Full Text]


Home page
CirculationHome page
H. J. Marshall, Z. I. Harris, M. J. Griffith, R. L. Holder, and M. D. Gammage
Prospective Randomized Study of Ablation and Pacing Versus Medical Therapy for Paroxysmal Atrial Fibrillation : Effects of Pacing Mode and Mode-Switch Algorithm
Circulation, March 30, 1999; 99(12): 1587 - 1592.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Olsson, B Darpö, L Bergfeldt, and M Rosenqvist
Frequency and long term follow up of valvar insufficiency caused by retrograde aortic radiofrequency catheter ablation procedures
Heart, March 1, 1999; 81(3): 292 - 296.
[Abstract] [Full Text]


Home page
CirculationHome page
J. T. Bigger Jr
Epidemiological and Mechanistic Studies of Atrial Fibrillation as a Basis for Treatment Strategies
Circulation, September 8, 1998; 98(10): 943 - 945.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dries, D. Exner, B. Gersh, M. Domanski, M. Waclawiw, and L. Stevenson
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials
J. Am. Coll. Cardiol., September 1, 1998; 32(3): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H J Marshall, Z I Harris, M J Griffith, and M D Gammage
Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation
Heart, June 1, 1998; 79(6): 543 - 547.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1995 BMJ Publishing Group Ltd & British Cardiovascular Society